{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:13:16Z","timestamp":1791177196561,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.beem.2010.08.008","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T06:42:41Z","timestamp":1299825761000},"page":"369-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The struggle for male hormonal contraception"],"prefix":"10.1016","volume":"25","author":[{"given":"Eberhard","family":"Nieschlag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2010.08.008_bib1","series-title":"Testosterone: action, deficiency, substitution","first-page":"514","year":"1998"},{"key":"10.1016\/j.beem.2010.08.008_bib2","unstructured":"Nieschlag E. Clinical trials in male hormonal contraception. Contraception, in press."},{"key":"10.1016\/j.beem.2010.08.008_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2006.12.001","article-title":"10th Summit Meeting group. 10th Summit Meeting: recommendations for regulatory approval for hormonal male contraception","volume":"75","author":"Nieschlag","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2010.08.008_bib4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jcem.87.2.8231","article-title":"Effects of testosterone enanthate plus medroxy-progesterone acetate on semen quality, reproductive hormones and germ cell populations in normal young men","volume":"87","author":"McLachlan","year":"2002","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004316.pub3","article-title":"Steroid hormones for contraception in men (review)","author":"Grimes","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.beem.2010.08.008_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","article-title":"Contraceptive efficacy of testosterone-induced azoospermia in normal men","volume":"336","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.08.008_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","article-title":"Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men","volume":"65","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2010.08.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(03)00577-6","article-title":"Development of methods of male contraception: impact of the World Health Organization Task Force","volume":"80","author":"Waites","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2010.08.008_bib9","first-page":"2394","article-title":"Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders","volume":"80","author":"Behre","year":"1995","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.2006.02618.x","article-title":"Testosterone treatment comes of age: new options for hypogonadal men","volume":"65","author":"Nieschlag","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2010.08.008_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/jc.2002-020447","article-title":"A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men","volume":"88","author":"Gu","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1210\/jc.2008-1846","article-title":"Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men","volume":"94","author":"Gu","year":"2009","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.contraception.2005.10.012","article-title":"The acceptability of an injectable, once-a-month male contraceptive in China","volume":"73","author":"Zhang","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2010.08.008_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(79)90084-2","article-title":"Pregnancies associated with sperm concentrations below 10 millionion\/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters","volume":"20","author":"Barfield","year":"1979","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2010.08.008_bib15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0015-0282(16)60735-5","article-title":"Combination of 19-nortestosterone-hexyoxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception","volume":"51","author":"Knuth","year":"1989","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2010.08.008_bib16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0015-0282(16)56411-5","article-title":"Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men","volume":"60","author":"World Health Organization Task Force on Methods for the Regulation of Male Fertility","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2010.08.008_bib17","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2003-030107","article-title":"Contraceptive efficacy of a depot gestagen and androgen combination in men","volume":"88","author":"Turner","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib18","first-page":"1","article-title":"The mother of the pill","volume":"50","author":"Djerassi","year":"1995","journal-title":"Recent Progress Hormone Research"},{"key":"10.1016\/j.beem.2010.08.008_bib19","first-page":"303","article-title":"Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception","volume":"86","author":"Kamischke","year":"2001","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate","volume":"90","author":"Meriggiola","year":"2005","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jcem.87.2.8218","article-title":"An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations","volume":"87","author":"Kamischke","year":"2002","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib22","author":"WHO"},{"key":"10.1016\/j.beem.2010.08.008_bib23","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1210\/jc.2009-0704","article-title":"Male hormonal contraception: love\u2019s labour\u2019s lost?","volume":"94","author":"Nieschlag","year":"2009","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib24","first-page":"112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism","volume":"84","author":"Wu","year":"1999","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1939-4640.2001.tb02157.x","article-title":"Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride","volume":"22","author":"Kinniburgh","year":"2001","journal-title":"Journal of Andrology"},{"key":"10.1016\/j.beem.2010.08.008_bib26","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/humrep\/deh491","article-title":"Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception","volume":"19","author":"Brady","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2010.08.008_bib27","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","article-title":"Male hormonal contraception: a double-blind, placebo-controlled study","volume":"93","author":"Mommers","year":"2008","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2010.08.008_bib28","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.08.008_bib29","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/jc.2007-2768","article-title":"Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis","volume":"93","author":"Liu","year":"2008","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4 Suppl.","key":"10.1016\/j.beem.2010.08.008_bib30","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.contraception.2008.04.117","article-title":"Male fertility control \u2013 where are the men?","volume":"78","author":"Darroch","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2010.08.008_bib31","series-title":"Andrology \u2013 male reproductive health and dysfunction","first-page":"589","article-title":"Pharmacological approach to male contraception","author":"Cooper","year":"2010"},{"key":"10.1016\/j.beem.2010.08.008_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2007-0041","article-title":"Advances in male contraception","volume":"29","author":"Page","year":"2008","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2010.08.008_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.contraception.2005.06.070","article-title":"Fertility control in wildlife: man as model","volume":"73","author":"Barfield","year":"2006","journal-title":"Contraception"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X1000093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X1000093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:43:32Z","timestamp":1761497012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X1000093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1521690X1000093X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2010.08.008","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The struggle for male hormonal contraception","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2010.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}